NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- Marex Group plc (Nasdaq: MRX) (“Marex” or the “Company”), a diversified global financial services platform, announced today that it is soliciting consents (the “Consents”) from each registered holder of its 6.404% Senior Notes due 2029 (the “Notes”) with respect to the adoption of certain proposed amendments (the “Proposed … [Read more...] about Marex Group plc Announces Commencement of Consent Solicitation for its 6.404% Senior Notes Due 2029

London, United Kingdom, May 07, 2026 (GLOBE NEWSWIRE) -- One-Click Automation + No Prior Experience Required; Designed to Help Users Explore Passive Income Through AI Trading A strategic combination of artificial intelligence and decentralised finance in 2026 is reshaping the global financial landscape. This is coupled with an ever-increasing number of borderless payment … [Read more...] about AiTradeBTC 2026 Launches Beginner-Friendly AI Trading Bot, Simplifying Access to Automated Earnings

TAMPA, Fla., May 07, 2026 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ: UPXI) (“Upexi” or the “Company”), a leading Solana-focused digital asset treasury company and consumer brands owner, today announced that Brian Rudick, Chief Strategy Officer, will present at the LD Micro Invitational XVI Conference being held at the Luxe Sunset Boulevard Hotel in Los Angeles, CA, on May … [Read more...] about Upexi to Present at the LD Micro Invitational XVI Conference on May 17-19

New initiative from Silo Pharma designed to align with federal actions to accelerate mental health innovation using psychedelic medicines Silo Pharma targets unmet need in a drug market with no FDA-approved therapies that address structural or regenerative aspects of traumatic brain injury Traumatic brain injury therapeutics market estimated to reach $6 billion by 2032 … [Read more...] about Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury

Investigational New Drug (IND) Application Filed to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple SclerosisTORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum” or the “Company”), has reported its financial and operational results for the first quarter of 2026, … [Read more...] about Quantum Reports Strengthened Liquidity, Reduced Cash Burn, and Disciplined Cost Management in First Quarter 2026

VICTORIA, Seychelles, May 07, 2026 (GLOBE NEWSWIRE) -- MEXC, the world leader in 0‑fee digital asset trading, announced the successful completion of the first month of its USD1 event series. The event attracted approximately 98,905 participants, while USD1-margined Futures achieved a cumulative trading volume of $1.3 billion. In addition, more than one million WLFI tokens … [Read more...] about MEXC USD1 Event Sees Strong First-Month Results: $1.3 Billion in Futures Volume & Nearly 100K Participants

HONG KONG, May 07, 2026 (GLOBE NEWSWIRE) -- April was a recovery month for Bitcoin, but not a clean risk-on month. BTC gained roughly 12% over April, rebounding from the weakness earlier in the year and trading back toward the high-$70,000 range by month-end. The key driver was not just spot momentum but the return of institutional demand: U.S. spot Bitcoin ETFs recorded … [Read more...] about CoinEx Monthly | The Two-Speed Market

HONG KONG, May 07, 2026 (GLOBE NEWSWIRE) -- CoinEx has officially completed its April 2026 CET repurchase and burning, continuing to execute its long-established token management mechanism with consistency and transparency. In an industry where trust is built through verifiable actions rather than promises, CoinEx’s monthly repurchase and burning program reflects a long-term … [Read more...] about CoinEx Completes April 2026 CET Repurchase and Burning, Reinforcing Transparency and Long-Term Commitment